Insulin degludec/Insulin aspart（Jilin Huisheng）
德谷胰岛素/门冬胰岛素（吉林惠升）
Report date: 2026/03/09 20:02:04
Base Information
Drug NameInsulin degludec/Insulin aspart（Jilin Huisheng）
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2024/07/30
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJilin Huisheng Biopharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesJilin Huisheng Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksKEGG